14일 이내에
1. 확진된 코로나바이러스 환자와 접촉을 한 사람은 발열 또는호흡기 증상/징후
2. Hubei 지역을 여행한 병력이 있는 사람은 발열 그리고호흡기 증상/징후
3. 중국 본토를 여행한 병력이 있는 사람은 입원을 요하는 발열 그리고호흡기 증상/징후
CDC clinical criteria for patients under investigation for 2019-nCoV infection
Clinical features |
|
Epidemiologic risk |
Fever* or signs/symptoms of lower respiratory illness (eg, cough or shortness of breath) |
PLUS |
Any person, including health care workers, who has had close contact¶ with a laboratory-confirmedΔ◊ 2019-nCoV patient within 14 days of symptom onset |
Fever* and signs/symptoms of lower respiratory illness (eg, cough or shortness of breath) |
PLUS |
A history of travel from Hubei Province, China within 14 days of symptom onset |
Fever* and signs/symptoms of lower respiratory illness (eg, cough or shortness of breath) requiring hospitalization◊ |
PLUS |
A history of travel from mainland China within 14 days of symptom onset |
nCoV: novel coronavirus; CDC: United States Centers for Disease Control and Prevention; NIOSH: National Institute for Occupational Safety and Health.
* Fever may be subjective or confirmed.
¶ CDC definition of close contact (any of following):
◆ Being within approximately 6 feet (2 meters) or within the room or care area of a 2019-nCoV case for a prolonged period of time while not wearing recommended personal protective equipment (eg, gowns, gloves, NIOSH-certified disposable N95 respirator, eye protection); close contact can include caring for, living with, visiting, or sharing a health care waiting area or room with a 2019-nCoV case.
◆ Having direct contact with infectious secretions of a 2019-nCoV case (eg, being coughed on) while not wearing recommended personal protective equipment.
Δ Documentation of laboratory confirmation of 2019-nCoV may not be possible for travelers or persons caring for patients in other countries.
◊ This category also includes any member of a cluster of patients with severe acute lower respiratory illness (eg, pneumonia, acute respiratory distress syndrome) of unknown etiology in whom 2019-nCoV is being considered that requires hospitalization. Such persons should be evaluated in consultation with state and local health departments regardless of travel history.
Reproduced from:
United States Centers for Disease Control and Prevention. Interim Guidance for Healthcare Professionals. https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html(Accessed January 31, 2020).
'감염내과 > 기타' 카테고리의 다른 글
수막구균백신 [메낙트라 (Menactra), 멘비오 (Menveo), 멘쿼디피 (MenQuadfi)] (0) | 2020.12.19 |
---|---|
아메바 장염의 진단과 치료, E. histolytica colitis and asymptomatic infection, diagnosis and treatment (0) | 2020.02.27 |
Coronavirus, 코로나바이러스 (0) | 2020.01.29 |
중국, 우한, 신종 코로나바이러스, Novel coronavirus in Wuhan, China (0) | 2020.01.26 |
2019 신종 코로나바이러스, 의심환자 기준, 2019-nCoV, PUI(Patients Under Investigation) criteria, 2020.01.26 (0) | 2020.01.26 |